Viewing nowCombinationWidiane Duo Tablets 12.5/1000 mg
Empagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Widders Pharmaceutical Co., Ltd.

MFDS item code 202302748 · Approved 2023.09.13 · Insurance code 660703960
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used in conjunction with diet and exercise to improve blood sugar control in adults with type 2 diabetes, as a combination of empagliflozin and metformin. It is particularly suitable for patients whose blood sugar is not sufficiently controlled and can be used cautiously in patients with cardiovascular diseases. Care is needed for the occurrence of cardiovascular events while taking this medication, and it is advisable to check relevant information. This medication can have a positive effect on cardiovascular health along with blood sugar management.
The recommended dose of this drug is 1 tablet twice daily. The dose should be determined based on each patient’s current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other drugs such as insulin, the recommended dose when taking this drug is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient’s current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this drug from concomitant therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive the same doses of empagliflozin and metformin that they were taking previously. When this drug is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see sections 4. Adverse Reactions and 6. Interactions under Precautions for Use). This drug should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this drug, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary in patients with mild renal impairment. Because this drug contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual single-ingredient products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this drug is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see item 1) under section 3. Patients Requiring Caution in Administration in Precautions for Use). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this drug should be discontinued immediately (see item 2) under section 2. Patients in Whom the Drug Must Not Be Administered in Precautions for Use). Elderly Patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication can cause serious side effects such as severe lactic acidosis; if such symptoms appear, immediate medical attention is required. Also, caution is needed as hypoglycemia may occur when used in combination with insulin or sulfonylurea medications. This medication should not be used in patients with moderate or severe renal impairment or in those with acute renal failure. Use should be stopped or approached with caution during unstable physical conditions such as acute infections, heart failure, or pre- and post-surgery. It is safer for pregnant or breastfeeding women not to take this medication. This medication helps with blood sugar control but may cause side effects such as hypoglycemia, urinary tract infection, genital infection, increased urination, nausea, vomiting, diarrhea, abdominal pain, loss of appetite, constipation, abnormal liver function tests, hepatitis, altered taste, itching, rash, erythema, hives, angioedema, urination difficulties, thirst, increased serum lipids, increased serum creatinine, decreased glomerular filtration rate, decreased fluid volume, headache, dizziness, weakness, chest discomfort, chest pain, fever, edema, fatigue, facial swelling, and insomnia. Additionally, blood vitamin B12 levels may decrease, so it is advisable to have regular blood tests. Alcohol consumption can increase the risk of lactic acidosis, so it should be avoided during treatment. During the use of this medication, kidney function and fluid status should be regularly monitored to ensure there are no abnormalities. If undergoing surgery or tests using iodinated contrast agents, this medication should be stopped for a certain period, and use should only resume after confirming normal kidney function. Elderly patients have a higher risk of renal function decline and fluid loss, so dosage adjustment and regular testing are necessary. In case of overdose, serious side effects like lactic acidosis may occur, so it should be taken exactly as directed by a physician. Finally, keep this medication out of reach of children and store it in its original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, ideally at room temperature between 1 and 30 degrees Celsius. Keeping it this way will help maintain the medication's efficacy.
Biconvex oval film-coated tablet with a dark brownish-purple color
30 tablets/bottle, 60 tablets/bottle, 60 tablets/box [10 tablets/PTP x 6], 10 tablets/box [10 tablets/PTP x 1]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Widders Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.